Study of GLS-5700 in Dengue Virus Seropositive Adults (Q26762063)
(Redirected from Q60563355)
Phase 1 clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of GLS-5700 in Dengue Virus Seropositive Adults |
Phase 1 clinical trial |
Statements
Phase I, Placebo-Controlled, Double-Blind Study To Evaluate The Safety, Tolerability, AND Immunogenicity Of GLS-5700, Administered ID Followed By Electroporation In Dengue Virus-Seropositive Adults (English)
0 references
31 August 2016
0 references
31 October 2017
0 references
160
0 references
18 year
0 references
65 year
0 references